In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Immunex nets $774mm in FOPO

Executive Summary

Immunex (immune system therapeutics) netted $774mm through a follow-on offering of 20mm shares at $39.75 apiece (the securities were filed under a shelf registration in August). American Home Products is selling 60.5mm of its Immunex shares, including a 10.5mm share overallotment, and will have a 41% stake in the company. The company had planned to price the shares at $46.19, looking to gross about $897mm.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies

UsernamePublicRestriction

Register